Veracyte (VCYT) Competitors

Veracyte (NASDAQ:VCYT) and Option Care Health (NASDAQ:OPCH) are both mid-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their community ranking, dividends, valuation, analyst recommendations, profitability, risk, media sentiment, earnings and institutional ownership.

Does the MarketBeat Community favor VCYT or OPCH?

Veracyte received 388 more outperform votes than Option Care Health when rated by MarketBeat users. Likewise, 73.14% of users gave Veracyte an outperform vote while only 64.00% of users gave Option Care Health an outperform vote.

Company	Underperform	Outperform
Veracyte	Outperform Votes 452 73.14%	Underperform Votes 166 26.86%
Option Care Health	Outperform Votes 64 64.00%	Underperform Votes 36 36.00%

Do analysts recommend VCYT or OPCH?

Veracyte currently has a consensus price target of $40.90, suggesting a potential upside of 40.07%. Option Care Health has a consensus price target of $35.50, suggesting a potential upside of 6.83%. Given Veracyte's higher possible upside, equities analysts plainly believe Veracyte is more favorable than Option Care Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Veracyte	1 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.70
Option Care Health	0 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.88

Is VCYT or OPCH more profitable?

Option Care Health has a net margin of 4.37% compared to Veracyte's net margin of -2.18%. Option Care Health's return on equity of 15.30% beat Veracyte's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Veracyte	-2.18%	3.02%	2.80%
Option Care Health	4.37%	15.30%	6.57%

Does the media refer more to VCYT or OPCH?

In the previous week, Veracyte had 4 more articles in the media than Option Care Health. MarketBeat recorded 15 mentions for Veracyte and 11 mentions for Option Care Health. Option Care Health's average media sentiment score of 1.73 beat Veracyte's score of 1.01 indicating that Option Care Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Veracyte	7 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
Option Care Health	10 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Which has preferable earnings & valuation, VCYT or OPCH?

Option Care Health has higher revenue and earnings than Veracyte. Option Care Health is trading at a lower price-to-earnings ratio than Veracyte, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Veracyte	$463.39M	4.93	-$74.40M	$0.41	71.22
Option Care Health	$5.19B	1.05	$267.09M	$1.24	26.80

Which has more risk and volatility, VCYT or OPCH?

Veracyte has a beta of 2.14, indicating that its stock price is 114% more volatile than the S&P 500. Comparatively, Option Care Health has a beta of 0.76, indicating that its stock price is 24% less volatile than the S&P 500.

Do insiders & institutionals have more ownership in VCYT or OPCH?

98.1% of Option Care Health shares are owned by institutional investors. 1.3% of Veracyte shares are owned by company insiders. Comparatively, 0.6% of Option Care Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Option Care Health beats Veracyte on 10 of the 18 factors compared between the two stocks.